Triple
T22492448
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Amphotericin B |
E556051
|
entity |
| Predicate | combinedWithFlucytosineUsedFor |
P20980
|
FINISHED |
| Object | induction therapy of cryptococcal meningitis |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: induction therapy of cryptococcal meningitis | Statement: [Amphotericin B, combinedWithFlucytosineUsedFor, induction therapy of cryptococcal meningitis]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: combinedWithFlucytosineUsedFor Context triple: [Amphotericin B, combinedWithFlucytosineUsedFor, induction therapy of cryptococcal meningitis]
-
A.
diseaseUsed
Indicates that a particular disease is employed or utilized as a tool, model, or condition within a given context or process.
-
B.
usesDrug
Indicates that an entity consumes, administers, or otherwise makes use of a specified drug.
-
C.
usesTreatment
Indicates that one entity applies or employs a particular treatment or therapeutic method on or for another entity.
-
D.
hasNoApprovedDrugTreatment
Indicates that there is currently no officially approved drug-based treatment available for the condition or situation in question.
-
E.
hasTargetDisease
chosen
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e5445bc8190b6a9481926db3355 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f15cb01b3481908a9143503b75167f |
completed | April 29, 2026, 1:19 a.m. |
| PD | Predicate disambiguation | batch_69e898be31448190be5ae7f5656f0497 |
completed | April 22, 2026, 9:45 a.m. |
Created at: April 16, 2026, 8:49 p.m.